selected publications
-
Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease.
Journal of Crohn's & colitis.
2025
Academic Article
GET IT
Times cited: 3 -
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) drives abnormal pericyte-rich vasculature in triple-negative breast cancer.
Angiogenesis.
2024
Academic Article
GET IT
Times cited: 2 -
Pro- and anti-inflammatory cytokines: the hidden keys to autoimmune gastritis therapy.
Frontiers in pharmacology.
2024
Review
GET IT
Times cited: 1 -
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion.
Cell reports.
2024
Academic Article
GET IT
Times cited: 6 -
Getting everyone to agree on gene signatures for murine macrophage polarization in vitro.
PloS one.
2024
Academic Article
GET IT
Times cited: 7 - Correction to "An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline". 2023 GET IT
-
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer.
Journal for immunotherapy of cancer.
2023
Academic Article
GET IT
Times cited: 15 - NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease. Frontiers in medicine. 2023 Academic Article GET IT
-
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease.
International journal of molecular sciences.
2023
Academic Article
GET IT
Times cited: 4 -
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction.
European journal of medicinal chemistry.
2022
Academic Article
GET IT
Times cited: 1 -
Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosis.
Communications biology.
2022
Academic Article
GET IT
Times cited: 11 -
An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline.
ACS medicinal chemistry letters.
2022
Academic Article
GET IT
Times cited: 12 - Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4. iScience. 2022 Academic Article GET IT
- Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer. Frontiers in pharmacology. 2021 Review GET IT
- A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro. Cancers. 2021 Academic Article GET IT
- Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity. Biology. 2020 Review GET IT
- Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy. Frontiers in pharmacology. 2020 Review GET IT
-
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis.
Journal of molecular medicine (Berlin, Germany).
2020
Academic Article
GET IT
Times cited: 52 - Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-a]pyridines against the 1A Family. ACS medicinal chemistry letters. 2020 Academic Article GET IT
-
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity.
Journal of medicinal chemistry.
2020
Academic Article
GET IT
Times cited: 55 -
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5).
Cells.
2020
Academic Article
GET IT
Times cited: 28 -
A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus.
The Journal of biological chemistry.
2020
Academic Article
GET IT
Times cited: 28 -
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group.
European journal of medicinal chemistry.
2019
Academic Article
GET IT
Times cited: 17 -
NAMPT: A pleiotropic modulator of monocytes and macrophages.
Pharmacological research.
2018
Review
GET IT
Times cited: 79